The Application and Challenge of Binder Jet 3D Printing Technology in Pharmaceutical Manufacturing
Xuejun Chen, Shanshan Wang, Jie Wu, Shuwei Duan, Xiaolong Wang, Xiaoxuan Hong, Xiaolu Han, Conghui Li, Dongzhou Kang, Zengming Wang, Aiping Zheng
Abstract
Three-dimensional (3D) printing is an additive manufacturing technique that creates objects under computer control. Owing to the rapid advancement of science and technology, 3D printing technology has been widely utilized in processing and manufacturing but rarely used in the pharmaceutical field. The first commercial form of Spritam® immediate-release tablet was approved by FDA in 2015, which promoted the advancement of 3D printing technology in pharmaceutical development. Three-dimensional printing technology is able to meet individual treatment demands with customized size, shape, and release rate, which overcomes the difficulties of traditional pharmaceutical technology. This paper intends to discuss the critical process parameters of binder jet 3D printing technology, list its application in pharmaceutical manufacturing in recent years, summarize the still-open questions, and demonstrate its great potential in the pharmaceutical industry.